microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4

Nobuko Tano1, Ha Won Kim, Muhammad Ashraf

  • 1Department of Pathology and Lab Medicine, University of Cincinnati, Cincinnati, Ohio, United States of America.

Plos One
|November 1, 2011
PubMed

Insights

Ischemia reduces miR-150, increasing CXCR4 and mobilizing bone marrow stem cells. This miR-150/CXCR4 pathway is crucial for stem cell migration to ischemic tissues, offering a new therapeutic target.

Area of Science:

  • Biomedical research
  • Stem cell biology
  • Molecular medicine

Background:

  • Chemokine receptor type 4 (CXCR4) and stromal cell-derived factor (SDF)-1 interaction is vital for stem cell function in ischemic tissues.
  • MicroRNAs (miRs) regulate stem cell survival and differentiation.
  • Ischemia's impact on stem cell mobilization and the miR-150/CXCR4 axis requires further elucidation.

Purpose of the Study:

  • To investigate the role of miR-150 in regulating CXCR4 expression and its impact on bone marrow-derived mononuclear cell (MNC) mobilization and migration in response to ischemia.
  • To explore the therapeutic potential of targeting the miR-150/CXCR4 pathway for stem cell-based tissue repair.

Main Methods:

  • Utilized a mouse acute myocardial infarction (MI) model to study stem cell behavior post-ischemia.
  • Employed microarray-based miRNA profiling and real-time PCR to analyze miR-150 expression.
  • Performed in vitro knockdown of miR-150 in MNCs and in vivo bone marrow transplantation experiments.

Main Results:

  • Ischemia significantly downregulated miR-150 expression in bone marrow MNCs, leading to increased CXCR4 protein levels.
  • Reduced miR-150 expression enhanced MNC migration in vitro and increased circulating MNCs in vivo after MI.
  • MNCs from miR-150 deficient bone marrow showed increased mobilization to peripheral blood following acute myocardial infarction.

Conclusions:

  • Ischemia induces bone marrow stem cell mobilization through a miR-150/CXCR4 dependent mechanism.
  • miR-150 acts as a negative regulator of CXCR4, controlling stem cell mobilization.
  • The miR-150/CXCR4 pathway represents a promising therapeutic target for enhancing stem cell migration to ischemic tissues for neovascularization and repair.